Stock Taper
EARNINGS CALL ARCHIVE 1 CALL ON FILE
CUE — Cue Biopharma, Inc.
NASDAQ
FULL STOCK PAGE →

Q2 2024 Earnings Call Summary

AUG 19, 2024
REVENUE
$2.7M +54.8%
NET MARGIN
-382.7% +336.4 PTS
EPS
-$6.00 +20.0%
FREE CASH FLOW
-$10.0M -1.6%

No summary has been written for this call yet.